4.92
-0.07(-1.40%)
Currency In USD
| Previous Close | 4.99 |
| Open | 4.97 |
| Day High | 4.97 |
| Day Low | 4.87 |
| 52-Week High | 7.08 |
| 52-Week Low | 2.61 |
| Volume | 3.25M |
| Average Volume | 1.53M |
| Market Cap | 624.41M |
| PE | -61.5 |
| EPS | -0.08 |
| Moving Average 50 Days | 4.68 |
| Moving Average 200 Days | 4.38 |
| Change | -0.07 |
If you invested $1000 in Organogenesis Holdings Inc. (ORGO) since IPO date, it would be worth $504.62 as of December 05, 2025 at a share price of $4.92. Whereas If you bought $1000 worth of Organogenesis Holdings Inc. (ORGO) shares 5 years ago, it would be worth $889.69 as of December 05, 2025 at a share price of $4.92.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Organogenesis Applauds CMS’s Significant Step In Payment Reform
GlobeNewswire Inc.
Nov 03, 2025 6:10 PM GMT
With evidence-based portfolio including technologies in each FDA category, we believe we are best positioned in the skin substitutes market for 2026 and beyondCANTON, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORG
Organogenesis Holdings Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Oct 31, 2025 8:05 PM GMT
CANTON, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (the “Company”) (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advance
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025
GlobeNewswire Inc.
Oct 01, 2025 8:05 PM GMT
CANTON, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and